U.S. Food Stock News

Earlier in June 2026, Applied Digital Corporation announced a new 15-year, take-or-pay lease at its Delta Forge 2 AI Factory campus with a U.S.-based investment-grade hyperscaler, covering 210 MW of critical IT load and adding an estimated US$5.20 billion in base-term contracted revenue. This latest agreement lifts Applied Digital’s portfolio to five AI Factory campuses with about US$36.00 billion in base-term lease revenue secured and around 70% of that backed by U.S.-based investment-grade...

Earlier this week, KeyBanc’s Christian Zyla initiated analyst coverage on PHINIA with a buy rating, while Vice President and Controller Samantha Pombier sold 2,227 shares on June 10, 2026, adding to a year of net insider selling activity. The combination of fresh institutional coverage with a positive view and ongoing insider share disposals offers investors contrasting signals about how the company is being assessed internally and externally. We’ll now examine how the new KeyBanc buy...

NeoGenomics (NEO) is back on investor radars after recent trading showed sharp short term swings, with the stock down over the past week but up strongly over the past month and past 3 months. See our latest analysis for NeoGenomics. Looking past the latest pullback, NeoGenomics has a 1 year total shareholder return of 50.07% despite a year to date share price decline of 10.80%. This suggests recent momentum has cooled after a strong rebound over the past quarter. If the recent swings in...

The U.S. Supreme Court declined to hear Macy's (NYSE:M) appeal of a labor board ruling. The decision leaves in place an order requiring Macy's to compensate dozens of unlawfully dismissed workers. This outcome affects Macy's legal, financial and reputational risk profile. Macy's operates a large department store chain in the U.S., with a focus on apparel, home goods and beauty products. The Supreme Court's decision adds a governance and labor relations angle to the discussion around NYSE:M,...

In the past quarter, Regions Financial reported Q1 results with revenue growing year on year but falling short of analyst expectations, while continuing to miss tangible book value per share estimates. What stands out is the bank’s ongoing push into digital banking and a new cloud-based core platform, as it seeks efficiency gains amid regulatory and competitive pressures on regional lenders. We’ll now examine how Regions Financial’s continued investment in digital infrastructure reshapes the...

Robotics and automation are moving from the lab floor into real factories, warehouses, and infrastructure projects just as tight labor markets, mixed inflation trends, and higher-for-longer global rates keep pressure on costs. With energy risks, shifting central bank policies, and uneven growth across the U.S., Europe, and Asia, many investors are looking for companies that can help lift productivity rather than simply ride the economic cycle. This Robotics and Automation Stocks screener...

Principal Financial Group (PFG) is drawing fresh attention after Principal Asset Management introduced Principal Fit, a suite of four fixed income ETFs designed to give investors more targeted bond market exposure. See our latest analysis for Principal Financial Group. Against this product launch backdrop, Principal Financial Group’s share price has climbed to $111.17, with a 30 day share price return of 10.58% and a 1 year total shareholder return of 52.05%. This points to strengthening...

Stubborn inflation at 4.2%, war related supply shocks, and a cautious Federal Reserve under Kevin Warsh are keeping interest rate and bond market risks front and center for U.S. investors. In this kind of cross‑current, many readers are asking which quality value stocks might hold up better if conditions stay bumpy, and which could benefit if policy eventually eases. Using a U.S. Quality Value Stocks screener focused on financially solid large and mid caps, this article highlights 3 stocks...

Dianthus Therapeutics (DNTH) drew fresh attention after reporting positive midstage results from its CAPTIVATE Phase 3 trial in chronic inflammatory demyelinating polyneuropathy, highlighting a high confirmed responder rate along with a favorable safety profile. See our latest analysis for Dianthus Therapeutics. The CAPTIVATE data arrived after a strong run in Dianthus Therapeutics, with the share price at $78.88 and a year to date share price return of 98.79%. Short term momentum has cooled,...

The Vita Coco Company (COCO) is back in focus after first quarter results significantly surpassed analyst forecasts for both earnings and revenue, delivering the largest estimate beat among its peer group. See our latest analysis for Vita Coco Company. The latest earnings beat has been followed by strong market interest, with Vita Coco Company’s share price at $83.87 and a 90 day share price return of 55.37%. The 1 year total shareholder return of 134.93% points to firm momentum rather than a...

Roper Technologies (ROP) recently extended its multi decade dividend growth streak with a 10.3% increase, a move that highlights the company’s focus on shareholder returns despite leverage concerns and industry disruption. See our latest analysis for Roper Technologies. The recent dividend hike comes after a difficult period for Roper Technologies’ shareholders, with the share price down 22.37% year to date and the 1 year total shareholder return declining 39.57%. This comes despite a 5.12% 1...

With Fed Chair Kevin Warsh expected to signal a firmer stance on interest rates and inflation still at 4.2%, the market is reassessing which financial sector stocks might benefit from a world of higher for longer borrowing costs. This article looks at three large banks and insurers from our Financial Sector Stocks screener that appear well placed, or at least less pressured, if rate cuts stay off the table. Each stock is exposed to the same Fed communication shift and interest rate...

Disc Medicine (IRON) stock is in focus after the company reported updated clinical data at the EHA Annual Meeting in Stockholm, highlighting results from its RALLY MF and HELIOS trials in hematologic disorders. See our latest analysis for Disc Medicine. At a share price of $69.83, Disc Medicine has seen a 90 day share price return of 18.02%, while the year to date share price return is down 11.71% and the 1 year total shareholder return is 39.41%. If fresh trial data has your attention, this...

Earlier this month, C.H. Robinson announced it has built an AI system that can run and continuously improve a shipper’s global supply chain, with its new Lean AI Engineer working alongside the existing Lean AI Planner to autonomously manage 92% of 4PL shipments across trucking, ocean, air and rail. Powered by a proprietary context layer built from institutional freight knowledge, the system can assess an entire supply chain in under half an hour and has already uncovered meaningful cost and...

AXIS Capital Holdings (NYSE:AXS) is drawing investor attention after its recent trading performance, with the stock last closing at $102.75. That price is a key reference point for how investors are weighing its value against recent return figures. See our latest analysis for AXIS Capital Holdings. The recent 7 day share price return of 5.26% stands in contrast to a year to date share price decline of 1.45%, while the 5 year total shareholder return of 139.88% points to a much stronger longer...

In recent weeks, Toll Brothers announced several product milestones, including final sales opportunities at Regency at Caramella Ranch and University Park, new openings in Texas and California, move-in ready homes in Maryland, and upcoming luxury communities in New Jersey and Florida, highlighting its continued rollout of high-end projects across key U.S. markets. These launches and sell-outs across diverse regions and price points illustrate how Toll Brothers is actively broadening its...

NCR Voyix Corporation recently presented at the RBC Capital Markets Global Financial Technology Conference 2026 in New York, where Executive Vice President and CFO Brian J. Webb-Walsh outlined the company’s financial technology positioning and corporate direction. This conference appearance gave investors direct access to senior leadership’s views on NCR Voyix’s evolving software, cloud, and payments-focused business model, potentially influencing how the market interprets its longer-term...

NextDecade (NEXT) stock is in focus after the company confirmed a new Chief Financial Officer, John Zuklic, and the election of Class C directors at its annual meeting on June 3, 2026. See our latest analysis for NextDecade. Those leadership updates come as NextDecade’s recent share price momentum has cooled, with the stock down 20.29% over the past month but still showing a 35.13% year to date share price return, compared with a weaker 1 year total shareholder return. If this kind of energy...

Mondelez International has appointed Amit Banati as Executive Vice President and Chief Financial Officer, effective July 1, 2026, with former CFO Luca Zaramella continuing as Executive Vice President and Chief Operating Officer overseeing global commercial operations. Banati’s long tenure across Kenvue, Kellanova, Procter & Gamble, Cadbury Schweppes and Kraft Foods brings deep consumer packaged goods and finance experience back into the Mondelez fold. We’ll explore how bringing back an...

With inflation, interest rate paths and growth signals pulling markets in different directions, many investors are looking for solid ground. That is where high quality undervalued stocks come in. This screener focuses on companies with healthy cash generation and sturdy balance sheets that the market has priced cautiously. In a world of mixed policy signals, fragile housing data and uneven manufacturing trends, that combination can appeal to investors who want substance behind every dollar...

Fortune Brands Innovations (FBIN) recently came into focus after its share price moved over the past month, prompting investors to reassess how the company’s fundamentals align with its current market valuation. See our latest analysis for Fortune Brands Innovations. Over the past month, Fortune Brands Innovations’ 30 day share price return of 23.63% contrasts with a year to date share price decline of 16.59% and a 1 year total shareholder return decline of 11.84%. This suggests recent...

In recent commentary, FIGS, the healthcare apparel company known for stylish scrubs, has been flagged for relatively weak demand, a shrinking active customer base, declining earnings per share over several years, and constrained free cash flow margins that limit reinvestment options. This combination of softer customer metrics and thinner cash generation is drawing renewed investor attention to whether FIGS’ business model can consistently convert brand awareness into profitable, sustainable...

Synaptics (SYNA) stock drew fresh attention after the company joined Accton Technology, Gallopwave, and Hsuan Yuan Technology in a Memorandum of Understanding focused on Edge AI for unmanned aerial vehicle applications. See our latest analysis for Synaptics. The MoU comes as Synaptics shares trade at US$134.94, with a 90 day share price return of 86.48% and a 1 year total shareholder return of 114.29%, suggesting momentum has been strong even though the 5 year total shareholder return is down...

ONEOK raises guidance after quarterly earnings beat ONEOK (OKE) recently reported quarterly results that exceeded prior expectations and lifted its full year net income guidance, a combination that sharpened investor focus on throughput trends, cross asset synergies and spread optimization. See our latest analysis for ONEOK. ONEOK stock has pulled back recently, with the 30 day share price return down 6.51% and the latest close at $86.31. However, the year to date share price return of 16.10%...